Tolerability of a Tunisian generic Docetaxel in early breast cancer: A prospective study
Journal of Oncology Pharmacy Practice
Published online on September 12, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundDocetaxel is a key component of chemotherapy for non-metastatic breast cancer. In Tunisia, Cytotere®, a local produced generic formulation of Docetaxel, has been used since 2017. Concerns have been raised regarding the safety of certain generic ...
BackgroundDocetaxel is a key component of chemotherapy for non-metastatic breast cancer. In Tunisia, Cytotere®, a local produced generic formulation of Docetaxel, has been used since 2017. Concerns have been raised regarding the safety of certain generic ...